What is Organon & Co. Quarterly Revenue?

Organon & Co. Quarterly Revenue Organon & Co. Jun-2026 Quarterly Revenue is $1,558 Million which is growth of -2.3% YoY.

What is Organon & Co. Quarterly Net Profit?

Organon & Co. Quarterly Net Profit Organon & Co. Jun-2026 Quarterly Net Profit is $108 Million which is growth of -25.5% YoY.

What is Organon & Co. Annual Revenue?

Organon & Co. Annual Revenue Organon & Co. Dec-2025 Annual Revenue is $6,216 Million which is growth of -2.9% YoY.

What is Organon & Co. Annual Net Profit?

Organon & Co. Annual Net Profit Organon & Co. Dec-2025 Annual Net Profit is $187 Million which is growth of -78.4% YoY.

What is Organon & Co. Total Shareholders Fund?

Organon & Co. Total Shareholders Fund Organon & Co. Dec-2025 Total Shareholders Fund is $752 Million which is growth of 59.3% YoY.

What is Organon & Co. Total Assets?

Organon & Co. Total Assets Organon & Co. Dec-2025 Total Assets is $12,867 Million which is growth of -1.8% YoY.

What is Organon & Co. Book Value Per Share?

Organon & Co. Book Value Per Share Organon & Co. Book Value Per Share is $4 which is growth of 109.4% YoY.

What is Organon & Co. ROE?

Organon & Co. ROE Organon & Co. ROE is 0% which is growth of 0% YoY.

What is Organon & Co. Cash From Operating Activity?

Organon & Co. Cash From Operating Activity Organon & Co. Dec-2025 Cash From Operating Activity is $700 Million which is growth of -25.5% YoY.

What is Organon & Co. Net Cash Flow?

Organon & Co. Net Cash Flow Organon & Co. Dec-2025 Net Cash Flow is $-251 Million which is growth of -532.8% YoY.

Organon & Co.

XNYS: OGN

Turnaround Potential

Download real time

0.06(0.44%)

New 52W High today

3.3M

XNYS Volume

XNYS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Organon & Co. quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Organon & Co. share price target, revenues, EPS, net income and more

Organon & Co. quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

NEGATIVE
Quarterly Revenue Organon & Co. Jun-2026 Quarterly Revenue is $1,558 Million which is growth of -2.3% YoY.
NEGATIVE
Quarterly Net Profit Organon & Co. Jun-2026 Quarterly Net Profit is $108 Million which is growth of -25.5% YoY.

Organon & Co., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
SR_Q Operating Rev.	1,558	1,460	1,507	1,602	1,594	1,513	1,592	1,582	1,607	1,622	1,598	1,519	1,608
CostOfRevenue_Q Cost Of Rev.	711	677	766	745	720	672	696	659	668	665	683	612	640
GrossProfit_Q Gross Profit	847	783	741	857	874	841	896	923	939	957	915	907	968
OEXPNS_Q Operating Exp. ⌄	524	517	524	499	548	516	600	533	553	543	603	675	579
AdminAndSellingExpenses_Q Admin Plus Selling Exp.	434	424	433	415	453	420	470	422	437	431	469	538	451
ResearchAndDevlopmentExpenses_Q RnD Exp.	90	93	91	84	95	96	130	111	116	112	134	137	128
OP_Q Operating Profit	323	266	217	358	326	325	296	390	386	414	312	232	389
NetNonOperIntIncExp_Q Net Non Operations Interest Incuding Expenses ⌄	-108	-111	-121	-128	-131	-124	-132	-126	-131	-131	-129	-134	-132
Others_Q Other Interest Earned	-	-	-	-	-	-	-	-	-	-	-	-	-
IntExpNonOperating_Q Interest Exp. Non Operating	108	111	121	128	131	124	132	126	131	131	129	134	132
PBT_Q Profit Before Tax	183	213	-148	243	229	101	129	207	235	236	104	80	254
TAX_Q Tax	75	67	57	83	84	14	20	-152	40	35	-442	22	12
NICommonStockholders_Q Net Income Common Stockholders ⌄	108	146	-205	160	145	87	109	359	195	201	546	58	242
NP_Q Net Profit	108	146	-205	160	145	87	109	359	195	201	546	58	242
NIIncludingNoncontrollingInterests_Q Net Income Including Non controlling Interests	108	146	-205	160	145	87	109	359	195	201	546	58	242
DilutedNIAvailtoComStockholders_Q Diluted NI Avail to Com Stockholders Ann.	108	146	-205	160	145	87	109	359	195	201	546	58	242
EPS_Q Basic EPS	0.4	0.6	-0.8	0.6	0.6	0.3	0.4	1.4	0.8	0.8	2.1	0.2	1
AfterDilutedEPS_Q Diluted EPS After ExtraOrdinary	0.4	0.7	0.2	0.7	0.6	0.6	0.5	1.6	0.8	0.9	2.4	0.3	1
SHARE_Q Number Of Shares End	262.6	260.4	260.2	260	259.9	257.9	257.7	257.5	257.3	255.7	255.6	255.6	255.3
NIContinuingDiscontinuedOper_Q Net Income Continuing Discontinued Operations	108	146	-205	160	145	87	109	359	195	201	546	58	242
NormalizedIncome_Q Normalized Income	119.1	188	165	263	261	265	235	226	289	315	226	223	336
InterestIncome_Q Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-
INT_Q Interest	108	111	121	128	131	124	132	126	131	131	129	134	132
NetInterestIncome_Q Net Interest Income	-108	-111	-121	-128	-131	-124	-132	-126	-131	-131	-129	-134	-132
EBIT_Q EBIT	291	324	-27	371	360	225	261	333	366	367	233	214	386
EBITDA_Q EBITDA	371	410	69	463	449	309	338	402	432	432	293	275	444
ReconciledCostOfRevenue_Q Reconciled Cost Of Rev.	711	677	766	745	720	672	696	659	668	665	683	612	640
ReconciledDepreciation_Q Reconciled Depr.	80	86	96	92	89	84	77	69	66	65	60	61	58
ProfitLossFromContinuingOperations_Q Profit From Continuing Operations	108	146	-205	160	145	87	109	359	195	201	546	58	242
NormalizedEBITDA_Q Normalized EBITDA	374	448	379	480	450	397	361	459	446	476	368	289	446

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Organon & Co. competitor comparison and performance snapshot within industry

Organon & Co. annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Annual Revenue Organon & Co. Dec-2025 Annual Revenue is $6,216 Million which is growth of -2.9% YoY.
NEGATIVE
Annual Net Profit Organon & Co. Dec-2025 Annual Net Profit is $187 Million which is growth of -78.4% YoY.

Organon & Co., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18
SR_A Total Rev. Ann. ⌄	0.2%	-5.1%		6,216	6,403	6,263	6,174	6,304	8,096	7,777	9,777
TotalOperatingRevenues_A Operating Rev. Ann.	0.2%	-5.1%	6,127	6,216	6,403	6,263	6,174	6,304	8,096	7,777	9,777
CostOfRevenue_A Cost Of Rev. Ann.	8.2%	-2.8%	2,899	2,903	2,688	2,515	2,294	2,382	3,347	2,274	4,693
GrossProfit_A Gross Profit Ann.	-5.1%	-6.9%	3,228	3,313	3,715	3,748	3,880	3,922	4,749	5,503	5,084
OEXPNS_A Operating Exp. Ann.	-1.4%	1.2%	2,064	2,087	2,229	2,421	2,175	2,111	1,970	1,663	2,378
OP_A Operating Profit Ann.	-10.4%	-15.1%	1,164	1,226	1,486	1,327	1,705	1,811	2,779	3,840	2,706
NetNonOperIntIncExp_A Net Non Operations Interest Incuding Expenses Ann, ⌄	-	-	-468	-504	-520	-527	-422	-258	-		-
Others_A Other Interest Earned Ann.	-	-		-	-	-	-	-	-	-	-
IntExpNonOperating_A Interest Exp. Non Operating Ann.	6.1%	-	468	504	520	527	422	258	-		-
OtherExpenses_A Other Exp. Ann.	-	-		-297	-159	-127	-161	-24	-99	-144	23
PBT_A PBT Ann.	-27.6%	-30.8%	491	425	807	673	1,122	1,529	2,680	3,696	2,729
TAX_A Tax Ann.	5.1%	-14.5%	282	238	-57	-350	205	178	520	390	576
NICommonStockholders_A Net Income Common Stockholders Ann. ⌄	-41.1%	-38.7%	209	187	864	1,023	917	1,351	2,160	3,218	2,153
NP_A Net Profit Ann.	-41.1%	-38.7%	209	187	864	1,023	917	1,351	2,160	3,218	2,153
NIIncludingNoncontrollingInterests_A Net Income Including Non controlling Interests Ann.	-41.1%	-38.7%	209	187	864	1,023	917	1,351	2,160	3,218	2,153
DilutedNIAvailtoComStockholders_A Diluted NI Avail to Com Stockholders Ann.	-41.1%	-38.7%	209	187	864	1,023	917	1,351	2,160	3,218	2,153
EPS_A EPS Ann.	-42.1%	-39.3%		0.7	3.4	4	3.6	5.3	8.5	12.7	8.5
DilutedEPS_A Diluted EPS Ann.	-42.1%	-39.3%		0.7	3.3	4	3.6	5.3	8.5	12.7	8.5
SHARE_Q Number Of Shares End	0.8%	0.6%		260.2	257.7	255.6	254.4	253.6	253.1	-	-
TotalExpenses_A Total Exp. Ann.	3.7%	-1.3%		4,990	4,917	4,936	4,469	4,493	5,317	3,937	7,071
NIContinuingDiscontinuedOper_A Net Income Continuing Discontinued Operations Ann.	-41.1%	-38.7%	209	187	864	1,023	917	1,351	2,160	3,218	2,153
NormalizedIncome_A Normalized Income Ann.	-9.4%	-11.6%	735.1	954	1,065	1,061	1,284	1,662	1,771	3,412.4	3,550
InterestIncome_A Interest Income Ann.	-	-		-	-	-	-	-	-	-	-
INT_A Interest Ann.	6.1%	-	468	504	520	527	422	258	-		-
EBITDA_A EBITDA Ann.	-9.8%	-14.6%	1,313	1,290	1,604	1,436	1,756	1,982	2,837	4,029	4,402
ReconciledCostOfRevenue_A Reconciled Cost Of Rev. Ann.	8.2%	-2.8%	2,899	2,903	2,688	2,515	2,294	2,382	3,347	2,274	4,693
ReconciledDepreciation_A Reconciled Depr. Ann.	19.4%	18.1%	354	361	277	236	212	195	157	333	1,673
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-41.1%	-38.7%	209	187	864	1,023	917	1,351	2,160	3,306	2,153
NormalizedEBITDA_A Normalized EBITDA Ann.	-3.6%	-10.7%	1,681	1,706	1,742	1,548	1,902	1,989	3,006	4,180	4,498

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

-2.9%

2Y CAGR

-0.4%

3Y CAGR

0.2%

5Y CAGR

-5.1%

7Y CAGR

-6.3%

Total Revenue Annual is falling faster than historical averages.

Net Profit Ann.

1Y CHG

-78.4%

2Y CAGR

-57.2%

3Y CAGR

-41.1%

5Y CAGR

-38.7%

7Y CAGR

-29.5%

Net Profit Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

-6.4%

2Y CAGR

-7.2%

3Y CAGR

-1.4%

5Y CAGR

1.2%

7Y CAGR

-1.8%

Operating Expenses Annual Cr is falling faster than historical averages.

Organon & Co. balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Organon & Co. Dec-2025 Total Shareholders Fund is $752 Million which is growth of 59.3% YoY.
NEGATIVE
Total Assets Organon & Co. Dec-2025 Total Assets is $12,867 Million which is growth of -1.8% YoY.

Organon & Co., Balance Sheet, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18
TA_A Total Assets Ann. ⌄	5.5%	4.3%	12,867	13,101	12,058	10,955	10,681	10,434	10,548	-
CA_A Total Current Assets Ann.	3.4%	4.9%	4,352	4,348	4,508	3,931	3,760	3,434	3,955	-
CashEquivalentsShortTermInvestments_A Cash Equivalents and Short Term Investments Ann.	-6.7%	2.8%	574	675	693	706	737	500	319	-
Receivables_A Change In Account Receivables Ann.	-3.4%	4%	1,331	1,358	1,744	1,475	1,382	1,092	1,487	-
Inventories_A Inventories Ann.	11.9%	9%	1,406	1,321	1,315	1,003	915	913	1,071	-
OtherCurrentAssets_A Other Current Assets Ann.	11.4%	2.1%	1,033	994	756	747	726	929	1,078	-
TotalNonCurrentAssets_A Total Non Current Assets Ann.	6.6%	4%	8,515	8,753	7,550	7,024	6,921	7,000	6,593	-
NetPPE_A Net PPE Ann.	8.6%	5.8%	1,303	1,168	1,183	1,018	973	984	680	-
InvestmentsAndAdvances_A Investments & Advances Ann.	-	-	-	-	-	-	-	-	-	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	36.8%	16.2%	1,929	1,491	1,231	754	694	910	741	-
TotalLiabilitiesNetMinorityInterest_A Total Liabilities Net Minority Interest Ann. ⌄	0.7%	1.5%	12,115	12,629	12,128	11,847	12,189	11,254	3,513	-
CL_A Total Current Liabilities Ann.	-1.6%	14.8%	2,390	2,718	2,918	2,512	2,597	1,201	1,341	-
PayablesAndAccruedExpenses_A Payables & Accrued Exp.s Ann.	-1.8%	14.6%	2,372	2,698	2,909	2,504	2,588	1,201	1,307	-
CurrentDebtCapLeaseObligation_A Current Debt Cap Lease Obligation Ann.	26%	-	16	20	9	8	9	-	34	-
CurrentDeferredLiabilities_Q Current Deferred Liabilities	-	-	-	-	-	-	-	-	-	-
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-88.1%	-70.1%	2	-	-	1,188	1,021	833	807	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann.	1.4%	-0.7%	9,725	9,911	9,210	9,335	9,592	10,053	2,172	-
LongTermDebtAndCapitalLeaseObligation_Q LT Debt & Capital Lease Obligation	-1%	-	8,628	8,860	8,751	8,905	9,125	-	-	-
TradeandOtherPayablesNonCurrent_A Trade & Other Payables Non Current Ann.	-	-	-	-	-	-	-	-	-	-
TotalDeferredCreditsAndOtherNonCurrentLiabilities_A Total Deferred Credits & Other Non Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	-	-	752	472	-70	-892	-1,508	-820	7,035	-
EQCAP_A Equity Share Capital Ann.	-	-	752	472	-70	-892	-1,508	-820	7,035	-
CapitalStock_A Capital Stock Ann.	0%	0%	3	3	3	3	3	3		-
RetainedEarnings_A Retained Earnings Ann.	-	-	1,109	1,010	443	-331	-998	-219		-
GainsLossesNotAffectingRetainedEarnings_A Gains Losses Not Affecting Retained Earnings Ann.	-	-	-527	-649	-541	-564	-513	-604	-914	-
TotalCapitalization_A Total Capitalization Ann.	5.4%	-	9,380	9,332	8,681	8,013	7,617	-820	7,105	-
TangibleAssets_A Tangible Assets Ann.	-	-	-4,531	-5,622	-5,206	-6,144	-6,762	-5,926	1,863	-
WC_A Working Capital Ann.	11.4%	-2.6%	1,962	1,630	1,590	1,419	1,163	2,233	2,614
InvestedCapital_A Invested Capital Ann.	5.4%	-	9,396	9,352	8,690	8,021	7,626	-820	7,139	-
TangibleBookValue_A Tangible Book Value Ann.	-	-	-4,531	-5,622	-5,206	-6,144	-6,762	-5,926	1,863	-
Borrowings_A Borrowings Ann.	-1%	-	8,644	8,880	8,760	8,913	9,134	-	104	-
NetDebt_A Net Debt Ann.	-0.6%	-	8,070	8,205	8,067	8,207	8,397	-	-	-
ShareIssued_A Share Issued Ann.	0.8%	0.5%	260.3	257.8	255.6	254.4	253.6	253.5	253.1	-
SHARE_Q Number Of Shares End	0.8%	0.6%	260.2	257.7	255.6	254.4	253.6	253.1	-	-

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Assets Ann.

1Y CHG

-1.8%

2Y CAGR

3.3%

3Y CAGR

5.5%

5Y CAGR

4.3%

Total Assets Annual is falling faster than historical averages.

Total Current Liabilities Ann.

1Y CHG

-12.1%

2Y CAGR

-9.5%

3Y CAGR

-1.6%

5Y CAGR

14.8%

Total Current Liabilities Annual Cr is falling faster than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

59.3%

Total ShareHolders Funds Annual growth is lower than historical averages.

Organon & Co. ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Organon & Co. Book Value Per Share is $4 which is growth of 109.4% YoY.
NEUTRAL
ROE Organon & Co. ROE is 0% which is growth of 0% YoY.

Organon & Co., Ratios, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18
ROA_A RoA Ann. %	-	-	-	6.87%	8.89%	8.48%	12.80%	20.59%	30.51%	-
ROE_A ROE Ann. %	-	-	-	429.85%	-	-	-	69.51%	45.74%	-
ROIC_Q ROIC %	-	-	-	2.4	-	-	-	-	-	-
OPMPCT_A OPM Ann. %	-10.6%	-10.5%	19.72%	23.21%	21.19%	27.62%	28.73%	34.33%	49.38%	27.68%
NBTO_A Inventory Turnover Ratio Ann.	-	-	-	2	2.2	2.4	2.6	3.4	2.1	-
ASETTO_A Asset Turnover Ann. %	-	-	-	0.5	0.5	0.6	0.6	0.8	0.7	-
WCTO_A Working Capital Turnover Ann.	-10.1%	-2.3%	3.2	3.9	3.9	4.4	5.4	3.6	3	-
QuickRatio_A Quick Ratio Ann.	-	-	-	0.8	0.8	0.9	0.8	1.3	1.4	-
CRATIO_A Current Ratio Ann.	-	-	-	1.6	1.5	1.6	1.5	2.9	3	-
IC_A Interest Coverage Ratio Ann.	-	-	-	2.6	2.3	3.7	6.9	-	-	-
LTDE_A LT Debt To Equity Ann.	-	-	-	18.8	-	-	-	-	0	-

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Organon & Co. cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Organon & Co. Dec-2025 Cash From Operating Activity is $700 Million which is growth of -25.5% YoY.
NEGATIVE
Net Cash Flow Organon & Co. Dec-2025 Net Cash Flow is $-251 Million which is growth of -532.8% YoY.

Organon & Co., Cash Flow, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18
CFO_A Cash from Operating Act. Ann. ⌄	-6.6%	-20.4%	700	939	799	858	2,160	2,187	3,020	3,687
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-41.1%	-38.7%	187	864	1,023	917	1,351	2,160	3,306	2,153
DepreciationAmortizationDepletion_A Depreciation Amortization Depletion Ann.	19.4%	18.1%	361	277	236	212	195	157	333	1,673
DepreciationAndAmortization_A Depreciation And Amortization Ann.	19.4%	18.1%	361	277	236	212	195	157	333	1,673
DeferredTax_A Deferred Tax Ann.	-	60%	63	-160	-485	-18	-288	6	12	37
DeferredIncomeTax_A Deferred Income Tax Ann.	-	60%	63	-160	-485	-18	-288	6	12	37
EmployeesStockOptions_A ESOPs Ann.	0.9%	7.4%	77	105	101	75	59	54	41	56
OtherNonCashItems_A Other Non Cash Items Ann.	-31.4%	-	43	133	39	133	116	-	-	10
ChangeInWorkingCapital_A Change In Working Capital Ann.	-	-	-247	-278	-155	-452	702	-197	-672	-174
ChangeInReceivables_A Change In Receivables Ann.	-	-13.1%	79	383	-212	-123	-277	159	200	250
ChangeInInventory_A Change In Inventory Ann.	-	-	-13	-131	-230	-220	-138	-29	-91	44
ChangePayablesAccruedExpense_A Change Payables Accrued Expense Ann.	-	-	-420	-323	281	-58	873	-209	-711	-316
ChangeInOtherCurrentAssets_A Change In Other Current Assets Ann.	-	-	-32	-236	-10	-43	353	108	-105	-161
ChangeInOtherCurrentLiabilities_A Change In Other Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-
ChangeInOtherWorkingCapital_A Change In Other Working Capital Ann.	-	-	139	29	16	-8	-109	-226	35	9
CFI_A Cash from Investing Act. Ann. ⌄	-	-	-390	-513	-260	-420	-481	-258	-88	-69
NetPPEPurchaseAndSale_A Net PPE Purchase & Sale Ann.	-47.7%	-45.1%	1	4	1	7	7	20	4	32
PurchaseOfPPE_A Purchase Of PPE Ann.	-	-	-	-	-	-	-	-	-	-
NetBusinessPurchaseAndSale_A Net Business Purchase & Sale Ann.	-	-	-75	-166	-	-	-	-	-	-
PurchaseOfBusiness_A Purchase Of Business Ann.	-	-	-75	-166	-	-	-	-	-	-
PurchaseOfInvestment_A Purchase Of Investment Ann.	-	-	-	-	-	-	-	-	-	-
SaleOfInvestment_A Sale Of Investment Ann.	-	-	-	-	-	-	-	-	-	-
NetOtherInvestingChanges_A Net Other Investing Changes Ann.	-	-	-	-	-	-	-	-	-	-
CFA_A Cash from Financing Act. Ann. ⌄	-	-	-561	-368	-569	-433	-977	-2,175	-2,932	-4,164
NetIssuancePaymentsOfDebt_A Net Issuance Payments Of Debt Ann.	-	-	-458	-11	-258	-108	7,846	1,165		59
NetLongTermDebtIssuance_A Net Long Term Debt Issuance Ann.	-	-	-458	-11	-258	-108	9,358	-79		18
NetShortTermDebtIssuance_A Net ST Debt Issuance Ann.	-	-	-	-			-1,512	1,244		41
NetCommonStockIssuance_A Net Common Stock Issuance Ann.	-	-	-	-	-	-	-	-	-	-
CommonStockIssuance_A Common Stock Issuance Ann.	-	-	-	-	-	-	-	-	-	-
CommonStockPayments_A Common Stock Payments Ann.	-	-	-	-	-	-	-	-	-	-
dividend_1Y_actual Dividend 1year	-35.2%	-	0.3	1.1	1.1	1.1	0.6
DividendPerShare_A Dividend Per Share Ann.	-	-	-88	-297	-294	-290	-145	-		-
NetOtherFinancingCharges_A Net Other Financing Charges Ann.	-	-	-15	-60	-17	-35	-8,678	-3,340	-2,932	-4,223
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-6.7%	52.3%	574	675	693	706	737	70	319	244
NetIncDecInCashAndCashEquivalents_A Net Increase In Cash Plus Cash Eqv.s Ann.	-	-	-251	58	-30	5	644	-246	44	-546
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-2.9%	16.2%	675	693	706	737	70	319	244	771
IncomeTaxPaidSupplementalData_A Income Tax Paid Supplemental Data Ann.	-	-	-	-	-	-	-	-	-	-
InterestPaidSupplementalData_A Interest Paid Supplemental Data Ann.	-	-	-	-	-	-	-	-	-	-
CapitalExpenditure_A Capex Ann.	-	-	-316	-351	-261	-427	-488	-278	-92	-101
IssuanceOfCapitalStock_A Issuance Of Capital Stock Ann.	-	-	-	-	-	-	-	-	-	-
IssuanceOfDebt_A Issuance Of Debt Ann.	-	-3.2%	1,055	1,186	80		9,470	1,244		59
RepaymentOfDebt_A Repayment Of Debt Ann.	-	-	-1,513	-1,197	-338	-108	-1,624	-79		-
RepurchaseOfCapitalStock_A Repurchase Of Capital Stock Ann.	-	-	-	-	-	-	-	-	-	-
FreeCashFlow_A Free Cash Flow Ann.	-3.8%	-27.4%	384	588	538	431	1,672	1,909	2,928	3,586

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

-25.5%

2Y CAGR

-6.4%

3Y CAGR

-6.6%

5Y CAGR

-20.4%

7Y CAGR

-21.1%

Cash from Operating Activity Annual is falling faster than historical averages.

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow

New 52W High today

Organon & Co. quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Organon & Co. - Forecaster

Forecaster Analyst Estimates for Organon & Co. share price target, revenues, EPS, net income and more

Organon & Co. - Earnings Report - Quarterly Results

Organon & Co. quarterly results: revenue, profit, and P&L – 13 quarter history

Quarterly Revenue Organon & Co. Jun-2026 Quarterly Revenue is $1,558 Million which is growth of -2.3% YoY.

Quarterly Net Profit Organon & Co. Jun-2026 Quarterly Net Profit is $108 Million which is growth of -25.5% YoY.

Organon & Co. - Competitors/Peers

Organon & Co. competitor comparison and performance snapshot within industry

Organon & Co. - Earnings Report - Annual Results

Organon & Co. annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Annual Revenue Organon & Co. Dec-2025 Annual Revenue is $6,216 Million which is growth of -2.9% YoY.

Annual Net Profit Organon & Co. Dec-2025 Annual Net Profit is $187 Million which is growth of -78.4% YoY.

Organon & Co. - Balance Sheet

Organon & Co. balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Total Shareholders Fund Organon & Co. Dec-2025 Total Shareholders Fund is $752 Million which is growth of 59.3% YoY.

Total Assets Organon & Co. Dec-2025 Total Assets is $12,867 Million which is growth of -1.8% YoY.

Organon & Co. - Ratios

Organon & Co. ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Book Value Per Share Organon & Co. Book Value Per Share is $4 which is growth of 109.4% YoY.

ROE Organon & Co. ROE is 0% which is growth of 0% YoY.

Organon & Co. - Cash Flow

Organon & Co. cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Cash From Operating Activity Organon & Co. Dec-2025 Cash From Operating Activity is $700 Million which is growth of -25.5% YoY.

Net Cash Flow Organon & Co. Dec-2025 Net Cash Flow is $-251 Million which is growth of -532.8% YoY.